MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 185.62 Thousand CAD | -38.46% |
| 2022 | 239.94 Thousand CAD | -17.1% |
| 2021 | 289.43 Thousand CAD | 7.96% |
| 2020 | 268.1 Thousand CAD | -44.12% |
| 2019 | 479.82 Thousand CAD | -30.38% |
| 2018 | 689.18 Thousand CAD | 12.16% |
| 2017 | 614.49 Thousand CAD | 40.35% |
| 2016 | 437.82 Thousand CAD | -33.83% |
| 2015 | 661.62 Thousand CAD | 35.85% |
| 2014 | 487.01 Thousand CAD | 57.18% |
| 2013 | 309.84 Thousand CAD | -27.73% |
| 2012 | 428.71 Thousand CAD | -12.64% |
| 2011 | 490.74 Thousand CAD | 18.86% |
| 2010 | 412.88 Thousand CAD | 273.75% |
| 2009 | -237.62 Thousand CAD | -128.48% |
| 2008 | 834.39 Thousand CAD | 21.94% |
| 2007 | 684.26 Thousand CAD | -66.2% |
| 2006 | 2.02 Million CAD | -11.05% |
| 2005 | 2.27 Million CAD | 1.64% |
| 2004 | 2.23 Million CAD | 102.04% |
| 2003 | 1.1 Million CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 55.06 Thousand CAD | 126.22% |
| 2024 Q1 | 24.34 Thousand CAD | 486.98% |
| 2023 FY | 147.67 Thousand CAD | -38.46% |
| 2023 Q4 | -6290.00 CAD | -109.58% |
| 2023 Q2 | 100.77 Thousand CAD | 439.24% |
| 2023 Q1 | 18.68 Thousand CAD | -82.77% |
| 2023 Q3 | 65.64 Thousand CAD | -34.86% |
| 2022 FY | 239.94 Thousand CAD | -17.1% |
| 2022 Q2 | 71.26 Thousand CAD | 189.12% |
| 2022 Q4 | 108.45 Thousand CAD | 204.81% |
| 2022 Q1 | 24.64 Thousand CAD | -84.94% |
| 2022 Q3 | 35.58 Thousand CAD | -50.07% |
| 2021 FY | 289.43 Thousand CAD | 7.96% |
| 2021 Q4 | 163.71 Thousand CAD | 12852.37% |
| 2021 Q1 | 48.96 Thousand CAD | -56.4% |
| 2021 Q2 | 75.48 Thousand CAD | 54.15% |
| 2021 Q3 | 1264.00 CAD | -98.33% |
| 2020 FY | 268.1 Thousand CAD | -44.12% |
| 2020 Q1 | 35.02 Thousand CAD | -63.06% |
| 2020 Q4 | 112.31 Thousand CAD | 38.98% |
| 2020 Q2 | 26.15 Thousand CAD | -25.32% |
| 2020 Q3 | 80.81 Thousand CAD | 208.94% |
| 2019 Q2 | 145.28 Thousand CAD | 56.28% |
| 2019 Q3 | 149.26 Thousand CAD | 2.74% |
| 2019 FY | 479.82 Thousand CAD | -30.38% |
| 2019 Q4 | 94.82 Thousand CAD | -36.47% |
| 2019 Q1 | 92.96 Thousand CAD | -53.28% |
| 2018 Q3 | 110.68 Thousand CAD | -56.08% |
| 2018 Q4 | 198.99 Thousand CAD | 79.78% |
| 2018 FY | 689.18 Thousand CAD | 12.16% |
| 2018 Q1 | 127.46 Thousand CAD | -29.4% |
| 2018 Q2 | 252.04 Thousand CAD | 97.74% |
| 2017 Q4 | 180.54 Thousand CAD | 24.53% |
| 2017 Q1 | 153.65 Thousand CAD | 1111.13% |
| 2017 Q2 | 135.31 Thousand CAD | -11.94% |
| 2017 FY | 614.49 Thousand CAD | 40.35% |
| 2017 Q3 | 144.97 Thousand CAD | 7.14% |
| 2016 Q2 | 113.9 Thousand CAD | -8.19% |
| 2016 Q1 | 124.06 Thousand CAD | 6.57% |
| 2016 Q3 | 188.12 Thousand CAD | 65.16% |
| 2016 FY | 437.82 Thousand CAD | -33.83% |
| 2016 Q4 | 12.68 Thousand CAD | -93.26% |
| 2015 FY | 661.62 Thousand CAD | 35.85% |
| 2015 Q1 | 178.36 Thousand CAD | 78.86% |
| 2015 Q4 | 116.41 Thousand CAD | 30.18% |
| 2015 Q3 | 89.42 Thousand CAD | -67.77% |
| 2015 Q2 | 277.42 Thousand CAD | 55.54% |
| 2014 FY | 487.01 Thousand CAD | 57.18% |
| 2014 Q3 | 161.12 Thousand CAD | 18.03% |
| 2014 Q2 | 136.51 Thousand CAD | 52.26% |
| 2014 Q1 | 89.65 Thousand CAD | 6.62% |
| 2014 Q4 | 99.72 Thousand CAD | -38.1% |
| 2013 Q1 | 64.37 Thousand CAD | -47.24% |
| 2013 Q4 | 84.08 Thousand CAD | 69.97% |
| 2013 FY | 309.84 Thousand CAD | -27.73% |
| 2013 Q2 | 111.92 Thousand CAD | 73.87% |
| 2013 Q3 | 49.47 Thousand CAD | -55.8% |
| 2012 FY | 428.71 Thousand CAD | -12.64% |
| 2012 Q4 | 122 Thousand CAD | 32.08% |
| 2012 Q3 | 92.37 Thousand CAD | -0.44% |
| 2012 Q2 | 92.77 Thousand CAD | -23.67% |
| 2012 Q1 | 121.55 Thousand CAD | -46.82% |
| 2011 Q4 | 228.57 Thousand CAD | 124.15% |
| 2011 Q2 | 95.19 Thousand CAD | 46.47% |
| 2011 Q1 | 64.99 Thousand CAD | -66.43% |
| 2011 FY | 490.74 Thousand CAD | 18.86% |
| 2011 Q3 | 101.97 Thousand CAD | 7.12% |
| 2010 Q1 | 104.84 Thousand CAD | 121.87% |
| 2010 FY | 412.88 Thousand CAD | 273.75% |
| 2010 Q2 | 32.66 Thousand CAD | -68.84% |
| 2010 Q3 | 88.94 Thousand CAD | 172.27% |
| 2010 Q4 | 193.59 Thousand CAD | 117.65% |
| 2009 Q2 | 28.98 Thousand CAD | -84.79% |
| 2009 Q1 | 190.59 Thousand CAD | -12.58% |
| 2009 FY | -237.62 Thousand CAD | -128.48% |
| 2009 Q3 | 22.14 Thousand CAD | -23.61% |
| 2009 Q4 | -479.35 Thousand CAD | -2264.89% |
| 2008 Q4 | 218.02 Thousand CAD | 18.95% |
| 2008 Q3 | 183.28 Thousand CAD | -20.03% |
| 2008 Q1 | 203.89 Thousand CAD | 1080.87% |
| 2008 Q2 | 229.19 Thousand CAD | 12.41% |
| 2008 FY | 834.39 Thousand CAD | 21.94% |
| 2007 Q2 | 257.71 Thousand CAD | 11.53% |
| 2007 Q1 | 231.07 Thousand CAD | -51.34% |
| 2007 Q3 | 216.27 Thousand CAD | -16.08% |
| 2007 Q4 | -20.78 Thousand CAD | -109.61% |
| 2007 FY | 684.26 Thousand CAD | -66.2% |
| 2006 Q2 | 564.36 Thousand CAD | -13.34% |
| 2006 Q1 | 651.26 Thousand CAD | 6.26% |
| 2006 FY | 2.02 Million CAD | -11.05% |
| 2006 Q3 | 380.64 Thousand CAD | -32.55% |
| 2006 Q4 | 474.9 Thousand CAD | 24.76% |
| 2005 Q4 | 612.91 Thousand CAD | 48.02% |
| 2005 FY | 2.27 Million CAD | 1.64% |
| 2005 Q1 | 567.33 Thousand CAD | 4.43% |
| 2005 Q2 | 681.63 Thousand CAD | 20.15% |
| 2005 Q3 | 414.07 Thousand CAD | -39.25% |
| 2004 FY | 2.23 Million CAD | 102.04% |
| 2004 Q1 | 385.89 Thousand CAD | 0.0% |
| 2004 Q3 | 574.31 Thousand CAD | -22.01% |
| 2004 Q4 | 543.26 Thousand CAD | -5.41% |
| 2004 Q2 | 736.39 Thousand CAD | 90.83% |
| 2003 FY | 1.1 Million CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | 99.555% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 18662.8% |
| Össur hf. | 485.57 Million USD | 99.962% |
| QHSLab, Inc. | 793.6 Thousand USD | 76.61% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.962% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | 96.393% |
| Aurora Spine Corporation | 8.21 Million USD | 97.739% |
| BrainsWay Ltd. | 23.09 Million USD | 99.196% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 60.199% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 99.471% |
| Vivos Inc. | -6036.00 USD | 3175.348% |
| Kelyniam Global, Inc. | 2.03 Million USD | 90.883% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 124.53% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 195.037% |
| Avitar, Inc. | 836.7 Thousand USD | 77.814% |
| Nanomix Corporation | -69.45 Thousand USD | 367.252% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 98.891% |
| Theraclion SA | -1.08 Million USD | 117.182% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -353.46 Thousand USD | 152.517% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 82.245% |
| Lombard Medical, Inc. | 955 Thousand USD | 80.563% |
| ALR Technologies Inc. | 4945.00 USD | -3653.852% |
| Stratec SE | 71.58 Million USD | 99.741% |
| Vycor Medical, Inc. | 1.31 Million USD | 85.891% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.965% |
| VMS Rehab Systems, Inc. | -10.44 USD | 1778145.977% |
| NewCardio, Inc. | 105.1 Thousand USD | -76.615% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -415.633% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 30.885% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -227.999% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 68.406% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 98.708% |
| IR-Med Inc. | -17 Thousand USD | 1191.929% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 10.072% |
| Polarean Imaging plc | 335.48 Thousand USD | 44.668% |
| United American Healthcare Corporation | -8000.00 USD | 2420.35% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 1538.977% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 83.033% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 89.445% |
| Urologix, Inc. | 6.09 Million USD | 96.953% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 158.615% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 73.982% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.995% |
| NIOX Group Plc | 28.13 Million USD | 99.34% |
| Fuse Medical, Inc. | 10.73 Million USD | 98.271% |
| Broncus Holding Corporation | 7.22 Million USD | 97.431% |
| Brain Scientific Inc. | 54.32 Thousand USD | -241.699% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 76.784% |
| Health Logic Interactive Inc. | - USD | -Infinity% |